DCAL.NS

Dishman Carbogen Amcis Limited

HealthcareBiotechnologyININRPeers →Country macro →

$170.72

+0.19%Jun 19, 2026

AI Brief

Market cap

$27.64B

52w range

—

P / E

—

EPS · FY 2026

$6.22

Volume

—

Revenue · FY 2026

$29.32B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Dishman Carbogen Amcis Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$170.72

Change

-29.83%

Period high

$314.40

Period low

$129.97

Period start

$243.302025-06-24

Through 2026-06-19

Fair value

Football field →

Weighted blend

$130.21

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

DCAL.NS

170.72-29.83%

H 321.95L 128.50MA50 182.10MA200 222.18Avg vol 357K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Consumer Cyclical
+1.38%
Technology
+1.20%
Utilities
+0.95%
Financial Services
+0.65%
Basic Materials
+0.60%
Industrials
+0.55%
Consumer Defensive
+0.42%
Energy
-0.17%
Communication Services
-0.38%
Healthcare
-0.39%
Real Estate
-0.54%

Top industries (issuer's industry highlighted)

Biotechnology
+8.74%
Business Equipment & Supplies
+5.50%
Furnishings, Fixtures & Appliances
+4.31%
Financial - Mortgages
+3.99%
Paper, Lumber & Forest Products
+3.45%
Electronic Gaming & Multimedia
+3.43%
Discount Stores
+3.22%
Home Improvement
+3.16%
Construction
+3.16%
Medical - Diagnostics & Research
+3.13%
Oil & Gas Drilling
-3.10%
Department Stores
+3.08%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DCAL.NS.

Financial scores

DBJun 23, 2026

Altman Z

0.68

Distress

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

3/9

Weak

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for DCAL.NS.

Total assets

$119.23B

Total debt

$30.76B

Cash & equiv

$9.91B

Operating CF

$3.45B

Free cash flow

$780.5M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$29.32B	$2.23B	$974.5M	$6.22	+3.32%